The COLOSSUS Project
Colorectal cancer is the third most common cancer in Europe. COLOSSUS is an EU-funded H2020 project that aims to provide new and more effective ways to classify patients with a specific type of colorectal cancer (microsatellite stable RAS mutant metastatic colorectal cancer or MSS RAS mt mCRC) and to develop better treatments for them. Our ultimate goal is to deliver a personalised medicine approach for patients with MSS RAS mt mCRC that is currently not available.
Project Partners
The COLOSSUS Project brings together a multidisciplinary team of 14 different partners from 8 different countries.
Latest News
Open Access review published in Gastroenterology by COLOSSUS researchers at RCSI and INSERM
Congratulations to authors Wolf H.Fridman, Ian Miller, CatherineSautès-Fridman, and Annette T.Byrne for their most recent paper published in Volume 158, Issue 2 edition of Gastroenterology dated January 2020, (pages 303-321). The open-access review is entitled: [...]
Cancer Trials Ireland features the COLOSSUS trial in its DSSG Winter 2019 Digest
COLOSSUS featured in the Cancer Trials Ireland publication, Winter 2019 DSSG Digest. You can download the full report here: http://bit.ly/2OvqN7G
Congratulations U of Torino PIs who published two more COLOSSUS papers!
Congratulations to all researchers involved in two COLOSSUS-acknowledged publications! The first, Immunogenomics of Colorectal Tumors: Facts and Hypotheses on an Evolving Saga, appears in the December 2019 edition of Trends in Cancer. The piece was [...]